Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as ...

The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...